Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Operating Leases: 2019-2025

Historic Operating Leases for Fortress Biotech (FBIO) over the last 7 years, with Sep 2025 value amounting to $12.8 million.

  • Fortress Biotech's Operating Leases fell 16.52% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year decrease of 16.52%. This contributed to the annual value of $14.8 million for FY2024, which is 19.32% down from last year.
  • Latest data reveals that Fortress Biotech reported Operating Leases of $12.8 million as of Q3 2025, which was down 4.04% from $13.3 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Operating Leases registered a high of $23.7 million during Q3 2022, and its lowest value of $12.8 million during Q3 2025.
  • Moreover, its 3-year median value for Operating Leases was $15.9 million (2024), whereas its average is $16.7 million.
  • Its Operating Leases has fluctuated over the past 5 years, first rose by 15.09% in 2023, then declined by 25.16% in 2024.
  • Over the past 5 years, Fortress Biotech's Operating Leases (Quarterly) stood at $21.0 million in 2021, then increased by 2.79% to $21.6 million in 2022, then decreased by 15.25% to $18.3 million in 2023, then fell by 19.32% to $14.8 million in 2024, then declined by 16.52% to $12.8 million in 2025.
  • Its Operating Leases stands at $12.8 million for Q3 2025, versus $13.3 million for Q2 2025 and $13.8 million for Q1 2025.